One-liner#

Evaluate wheezing to differentiate asthma and COPD (most common) from cardiac causes, upper airway obstruction, and focal lesions, recognizing that “all that wheezes is not asthma.”

Quick nav#

Red flags / send to ED#

  • Severe respiratory distress: SpO₂ <92%, accessory muscle use, inability to speak in full sentences
  • Stridor (inspiratory wheeze) suggesting upper airway obstruction
  • Unilateral wheeze with acute onset (foreign body, tumor, mucus plug)
  • Anaphylaxis: wheeze + urticaria + angioedema + hypotension
  • Silent chest in known asthmatic (severe bronchospasm, impending respiratory failure)
  • New wheeze with hemoptysis (PE, malignancy)
  • Wheeze not responding to bronchodilators with worsening distress

Key history#

Wheeze characteristics:

  • Timing: inspiratory (upper airway), expiratory (lower airway), biphasic (fixed obstruction)
  • Onset: acute (asthma exacerbation, anaphylaxis, foreign body) vs chronic (COPD, asthma)
  • Location: diffuse (asthma, COPD) vs focal/unilateral (tumor, foreign body, mucus plug)
  • Triggers: allergens, exercise, cold air (asthma); infections (COPD, asthma); position (cardiac)

Associated symptoms:

  • Dyspnea: severity, timing, positional component
  • Cough: productive (COPD, bronchiectasis) vs dry (asthma)
  • Chest tightness: asthma, cardiac
  • Orthopnea/PND: heart failure (“cardiac asthma”)
  • Fever: infection
  • Urticaria, angioedema: anaphylaxis
  • Heartburn: GERD-triggered asthma
  • Weight loss, hemoptysis: malignancy

Past medical history:

  • Known asthma or COPD: baseline control, recent exacerbations, current medications
  • Cardiac disease: HF, valvular disease
  • Allergies: environmental, food, drug
  • Prior intubation for asthma (high-risk)

Smoking history:

  • Pack-years (COPD risk)
  • Current vs former

Medication review:

  • Beta-blockers: can trigger bronchospasm (even eye drops)
    • If beta-blocker needed for cardiac indication in asthmatic: use cardioselective (metoprolol, bisoprolol) at lowest effective dose; monitor closely
    • Avoid non-selective (propranolol, carvedilol) in asthmatics
  • NSAIDs/aspirin: aspirin-exacerbated respiratory disease (AERD)
  • ACE inhibitors: cough (not wheeze, but often confused)
  • Current asthma/COPD medications and adherence

Inhaler technique (assess at every visit):

  • Poor technique is a common cause of “uncontrolled” asthma
  • MDI requires coordination; spacer improves delivery
  • DPI requires adequate inspiratory flow
  • Demonstrate and observe technique; correct errors

Occupational/environmental:

  • Occupational asthma: symptoms worse at work, improve on weekends/vacation
  • Allergen exposure: pets, dust, mold
  • Irritant exposure: smoke, fumes, chemicals

Focused exam#

  • Vitals: SpO₂ (most important), RR, HR, BP
  • General: respiratory distress, ability to speak in full sentences, use of accessory muscles
  • HEENT: nasal polyps (AERD, allergic rhinitis), angioedema, stridor
  • Neck: JVD (HF), tracheal position, goiter
  • Lungs:
    • Wheeze location: diffuse vs focal vs unilateral
    • Wheeze timing: inspiratory (upper airway) vs expiratory (lower airway) vs biphasic
    • Breath sounds: decreased (severe obstruction, effusion), absent unilaterally (pneumothorax)
    • Crackles: HF, pneumonia
    • Prolonged expiratory phase: obstructive disease
  • Cardiac: S3 (HF), murmurs, irregular rhythm
  • Skin: urticaria, eczema (atopy)
  • Extremities: edema (HF), clubbing

Severity assessment (asthma/COPD):

  • Mild: speaks in sentences, SpO₂ >94%, no accessory muscles
  • Moderate: speaks in phrases, SpO₂ 90–94%, some accessory muscle use
  • Severe: speaks in words, SpO₂ <90%, accessory muscles, agitation
  • Life-threatening: silent chest, cyanosis, altered mental status, bradycardia

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Asthma“Wheezing,” “tight chest,” “inhaler helps”Episodic; triggers (allergens, exercise, cold); nocturnal; personal/family atopyDiffuse expiratory wheezes; prolonged expiration; may be normal between episodesBronchodilator trial; spirometry if stable
COPD“Smoker’s wheeze,” “always short of breath”Smoking history; chronic progressive dyspnea; productive coughDiffuse wheezes; decreased breath sounds; barrel chest; prolonged expirationSpirometry (FEV1/FVC <0.70 post-BD)
Asthma exacerbation“Inhaler not working,” “can’t catch my breath”Known asthma; trigger exposure; worsening over hours-daysDiffuse wheezes; tachypnea; accessory muscles if severeBronchodilators + steroids; assess severity
COPD exacerbation“Flare-up,” “more mucus,” “worse than usual”Known COPD; increased dyspnea, sputum, purulenceWheezes; decreased breath sounds; may have feverBronchodilators + steroids ± antibiotics
Viral URI with reactive airways“Cold went to my chest”Recent URI; mild wheezing; no significant distressMild diffuse wheezes; otherwise wellBronchodilator PRN; supportive care
GERD-triggered bronchospasm“Wheeze after eating,” “worse lying down”Heartburn; nocturnal symptoms; wheeze with reflux symptomsMay have wheezes; often normalPPI trial; asthma treatment if concurrent

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Cardiac asthma (HF)“Can’t breathe lying down,” “swollen legs”Orthopnea, PND; edema; cardiac history; wheeze + cracklesBilateral crackles AND wheezes; JVD; S3; edemaBNP; CXR; diuretics; cardiology
Anaphylaxis“Throat closing,” “hives,” “can’t breathe”Allergen exposure; rapid onset; urticaria; angioedemaUrticaria; angioedema; stridor; wheezes; hypotensionEpinephrine IM immediately; call 911
Foreign body aspiration“Choked on something,” “sudden wheeze”Sudden onset; choking episode; unilateral wheezeUnilateral wheeze; decreased breath sounds on one sideCXR; bronchoscopy if suspected
Endobronchial tumor“Wheeze won’t go away,” “coughing blood”Smoker; persistent focal wheeze; hemoptysis; weight lossFocal/unilateral wheeze; may have lymphadenopathyCXR → CT chest; bronchoscopy
Vocal cord dysfunction (VCD)“Can’t get air in,” “throat tight”Inspiratory stridor/wheeze; often young female; anxiety; doesn’t respond to bronchodilatorsInspiratory stridor; normal SpO₂; normal between episodesLaryngoscopy during episode; speech therapy
Upper airway obstruction“Can’t breathe,” “noisy breathing”Stridor; history of intubation, surgery, or tumorInspiratory stridor; may have voice changesDirect visualization; ENT/ED referral
Pulmonary embolism“Sudden shortness of breath,” “chest pain”PE risk factors; acute onset; pleuritic pain; may have wheezeTachycardia; tachypnea; hypoxia; wheeze less commonWells score; D-dimer or CT-PA

Workup#

Immediate assessment:

  • SpO₂ on room air
  • Respiratory rate and work of breathing
  • Ability to speak in full sentences

Office workup:

TestWhen to orderWhat it tells you
Pulse oximetryAll patientsSeverity; need for supplemental O₂
Peak flowKnown asthma; assess severity and response to treatment<50% predicted = severe; <25% = life-threatening
Spirometry (pre/post-BD)Stable patient; new diagnosis; differentiate asthma vs COPDObstruction (FEV1/FVC <0.70); reversibility (≥12% and 200 mL improvement = asthma)
CXRNew wheeze; focal wheeze; not responding to treatment; suspected HF or pneumoniaHyperinflation, infiltrate, mass, cardiomegaly, effusion
BNPSuspected cardiac cause; differentiate cardiac vs pulmonaryElevated in HF
CBCSuspected infection; eosinophilia (allergic/eosinophilic asthma)WBC; eosinophil count

When to order additional testing:

TestIndication
CT chestFocal wheeze; suspected mass; abnormal CXR
Methacholine challengeNormal spirometry but asthma suspected
LaryngoscopySuspected VCD or upper airway pathology
Allergy testingSuspected allergic asthma; identify triggers
EchocardiogramSuspected cardiac cause; elevated BNP

When NOT to order:

  • Spirometry during acute exacerbation (wait until stable)
  • CT chest for typical asthma/COPD with normal CXR
  • Extensive workup for clear viral URI with reactive airways

Initial management#

Acute bronchospasm (asthma/COPD exacerbation):

  1. Assess severity (see severity assessment above)
  2. Bronchodilators:
    • Albuterol nebulizer 2.5 mg OR MDI 4–8 puffs via spacer
    • Can repeat every 20 minutes x 3 for moderate-severe
    • Add ipratropium 0.5 mg nebulizer for moderate-severe
  3. Systemic steroids:
    • Prednisone 40–60 mg PO (or methylprednisolone if unable to take PO)
    • Start early; reduces treatment failure and relapse
  4. Reassess after initial treatment:
    • Good response: discharge with bronchodilators + steroids + follow-up
    • Partial response: continue treatment; consider ED if not improving
    • Poor response: send to ED

Suspected cardiac wheeze:

  • Diuretics (furosemide 40–80 mg IV/PO)
  • Upright positioning
  • Supplemental O₂ if hypoxic
  • Bronchodilators may help symptomatically but treat underlying HF

Suspected anaphylaxis:

  • Epinephrine 0.3–0.5 mg IM (1:1000) in anterolateral thigh
  • Call 911
  • Repeat epinephrine in 5–15 minutes if no improvement

Management by diagnosis#

Asthma#

Education:

  • Chronic airway inflammation with reversible obstruction
  • Controller medications (ICS) prevent symptoms; rescue medications (SABA) treat acute symptoms
  • Identify and avoid triggers
  • Asthma action plan for self-management

Treatment:

Acute exacerbation:

DrugDoseContraindicationsMonitoringCostNotes
Albuterol nebulizer2.5 mg Q20min x 3, then Q1–4HTachyarrhythmiasHR, tremor$First-line bronchodilator
Albuterol MDI + spacer4–8 puffs Q20min x 3SameSame$Equivalent to nebulizer if good technique
Ipratropium nebulizer0.5 mg Q20min x 3 (with albuterol)Glaucoma; urinary retentionNone$Add for moderate-severe
Prednisone40–60 mg PO daily x 5 daysUncontrolled diabetes (relative)Blood glucose$Start early; no taper needed

Maintenance therapy (see Asthma section in Dyspnea Chronic page for full stepwise approach):

DrugDoseContraindicationsMonitoringCostNotes
Fluticasone MDI44–220 mcg BIDNone significantOral thrush$ICS; mainstay of controller therapy
Budesonide/formoterol (Symbicort)80/4.5 or 160/4.5 mcg, 2 puffs BIDTachyarrhythmiasHR$$ICS-LABA; can use as MART
Montelukast10 mg dailyNeuropsychiatric effects (boxed warning)Mood changes$Add-on; less effective than ICS
Albuterol MDI2 puffs Q4–6H PRNTachyarrhythmiasHR$Rescue inhaler

Follow-up: Reassess in 1–2 days if moderate exacerbation. Review maintenance therapy; step up if needed.


COPD#

Education:

  • Chronic, progressive airflow obstruction from smoking (usually)
  • Smoking cessation is most important intervention
  • Medications control symptoms and reduce exacerbations

Treatment:

Acute exacerbation:

DrugDoseContraindicationsMonitoringCostNotes
Albuterol nebulizer2.5 mg Q4–6H (more frequent acutely)TachyarrhythmiasHR$Increase frequency during exacerbation
Ipratropium nebulizer0.5 mg Q6HGlaucoma; urinary retentionNone$Add to albuterol
Prednisone40 mg PO daily x 5 daysUncontrolled diabetes (relative)Blood glucose$Shortens recovery
Azithromycin500 mg day 1, then 250 mg days 2–5QT prolongationNone$If increased sputum purulence

Maintenance therapy (see COPD section in Dyspnea Chronic page for full GOLD-based approach)

Follow-up: Reassess in 48–72 hours. Review maintenance therapy after recovery.


Cardiac Asthma (Heart Failure)#

Education:

  • Wheezing caused by pulmonary congestion from heart failure
  • Fluid in lungs causes airway narrowing and bronchospasm
  • Treating the heart failure resolves the wheeze

Recognition:

  • Wheeze + orthopnea + edema + JVD
  • Bilateral crackles in addition to wheezes
  • Elevated BNP
  • CXR shows cardiomegaly, pulmonary edema

Treatment:

  • Diuretics are primary treatment (not bronchodilators)
  • Furosemide 40–80 mg PO/IV
  • Bronchodilators may provide symptomatic relief but don’t address cause
  • Optimize HF medications (see HF section in Dyspnea Chronic page)

Follow-up: Cardiology referral if new diagnosis. Close follow-up for diuresis.


Vocal Cord Dysfunction (VCD)#

Education:

  • Paradoxical vocal cord adduction during inspiration
  • Causes inspiratory stridor often mistaken for asthma
  • Does NOT respond to bronchodilators
  • Often associated with anxiety, GERD, or post-nasal drip
  • Diagnosis requires laryngoscopy during symptomatic episode

Recognition:

  • Inspiratory stridor/wheeze (not expiratory)
  • Throat tightness, difficulty getting air IN
  • Normal SpO₂ during episodes
  • Does not respond to albuterol
  • Often young female; may have anxiety

Treatment:

  • Acute: reassurance, relaxation techniques, panting breaths
  • Long-term: speech therapy (laryngeal control techniques)
  • Treat comorbidities: GERD, post-nasal drip, anxiety
  • Avoid unnecessary asthma medications

Follow-up: ENT or pulmonology referral for laryngoscopy. Speech therapy referral.


Anaphylaxis#

Education:

  • Severe allergic reaction; life-threatening emergency
  • Requires immediate epinephrine
  • All patients need epinephrine auto-injector prescription and allergist referral

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Epinephrine (1:1000)0.3–0.5 mg IM in anterolateral thighNone in anaphylaxisHR, BP$First-line; repeat Q5–15min PRN
Diphenhydramine25–50 mg IV/IM/POGlaucoma; urinary retentionSedation$Adjunct; does NOT replace epinephrine
Famotidine20 mg IV/PONone significantNone$H2 blocker; adjunct
Methylprednisolone125 mg IVNone in emergencyNone$Prevents biphasic reaction; not first-line

Post-anaphylaxis:

  • Observe 4–6 hours (biphasic reactions can occur)
  • Prescribe epinephrine auto-injector (EpiPen, Auvi-Q)
  • Allergist referral for trigger identification
  • Anaphylaxis action plan

Aspirin-Exacerbated Respiratory Disease (AERD)#

Education:

  • Triad: asthma + nasal polyps + aspirin/NSAID sensitivity
  • Respiratory reaction (not anaphylaxis) to COX-1 inhibitors
  • Chronic rhinosinusitis with nasal polyps
  • Often severe, difficult-to-control asthma

Recognition:

  • Asthma + nasal polyps + history of reaction to aspirin/NSAIDs
  • Reaction is respiratory (wheeze, nasal congestion), not urticaria/anaphylaxis

Treatment:

  • Avoid all NSAIDs and aspirin (acetaminophen usually safe)
  • Aggressive asthma management (often requires high-dose ICS-LABA)
  • Nasal steroids and saline irrigation for polyps
  • Consider aspirin desensitization (specialist-directed)
  • Biologics (dupilumab) for severe cases

Follow-up: Pulmonology and ENT co-management. Allergist for aspirin desensitization consideration.

Follow-up#

Default intervals:

  • Asthma exacerbation: reassess in 1–2 days; follow-up in 2–4 weeks
  • COPD exacerbation: reassess in 48–72 hours; follow-up in 2–4 weeks
  • New asthma diagnosis: follow-up in 2–4 weeks to assess control
  • Cardiac wheeze: close follow-up for diuresis; cardiology referral

Referral thresholds:

  • Pulmonology: severe/uncontrolled asthma, COPD with FEV1 <50%, diagnostic uncertainty
  • Cardiology: cardiac wheeze/HF
  • Allergist: anaphylaxis, suspected allergic asthma, AERD
  • ENT: VCD, nasal polyps, upper airway pathology

Return precautions:

  • Worsening shortness of breath or wheeze
  • Inhaler not helping
  • Difficulty speaking in full sentences
  • Blue lips or fingernails
  • Chest pain
  • Swelling of face, lips, or throat

Patient instructions#

  • Wheezing is a whistling sound when you breathe, usually caused by narrowed airways. The most common causes are asthma and COPD.
  • If you have asthma or COPD, take your controller medications every day, even when you feel well. Use your rescue inhaler (albuterol) when you have symptoms.
  • Know your triggers and avoid them when possible. Common triggers include smoke, dust, pet dander, cold air, and respiratory infections.
  • If you smoke, quitting is the most important thing you can do for your breathing.
  • Seek emergency care if your breathing gets much worse, your inhaler isn’t helping, you can’t speak in full sentences, or your lips turn blue.
  • If you had an allergic reaction with wheezing, always carry your epinephrine auto-injector and know how to use it.

Smartphrase snippets#

.WHEEZEASTHMA Wheezing consistent with asthma [exacerbation / new diagnosis]. SpO₂ [X]% on room air. Treated with albuterol [nebulizer / MDI] with [good / partial / poor] response. Started prednisone 40 mg daily x 5 days. Discharged with albuterol PRN and [ICS / ICS-LABA]. Asthma action plan reviewed. Return precautions discussed. Follow-up in [1–2 days / 2–4 weeks].

.WHEEZECOPD COPD exacerbation with wheezing. SpO₂ [X]% on room air. Started prednisone 40 mg x 5 days, increased bronchodilator frequency, [added azithromycin for purulent sputum / no antibiotics indicated]. Discussed return precautions. Reassess in 48–72 hours.

.WHEEZECARDIAC Wheezing with bilateral crackles, JVD, and peripheral edema consistent with cardiac asthma (heart failure exacerbation). BNP elevated at [X]. Started/increased furosemide to [dose]. Bronchodilators for symptomatic relief. Cardiology referral placed. Close follow-up for diuresis.